NCT00000322

Tyrosine for Methamphetamine Dependence - 1

Tyrosine for Methamphetamine Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 89 (planned)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment, and craving."

Detailed description

Evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment and craving.

Conditions

• Amphetamine-Related Disorders

Interventions

Type	Name	Description
BEHAVIORAL	Tyrosine

Timeline

• Start date: 1997-04-01
• Completion: 2001-12-01
• First posted: 1999-09-21
• Last updated: 2017-01-12

Locations

1 site across 1 country: United States